{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:45:05Z","timestamp":1794203105668,"version":"4.8.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Advanced liver fibrosis is a major determinant of liver-related morbidity and mortality and occurs more frequently in individuals with type 2 diabetes mellitus (T2DM). While metabolic dysfunction\u2013associated steatotic liver disease (MASLD) is highly prevalent among patients with T2DM, data on the risk of advanced liver fibrosis in this population in the United Arab Emirates (UAE) remain limited. Non-invasive fibrosis scores offer a pragmatic approach for risk stratification in routine clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To determine the prevalence of high risk for advanced liver fibrosis and its clinical associations among patients with T2DM in the UAE using validated non-invasive fibrosis scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>A retrospective cross-sectional study was conducted between October to December 2023, enrolling T2DM patients who attended at the Diabetic Care Centre in Dubai, UAE. Data was extracted from the Dubai Health electronic medical records, Epic (Salama). Liver fibrosis risk was assessed using the fibrosis-4 (FIB-4) score and Nonalcoholic Fatty Liver Disease (NAFLD) fibrosis score, with chi-square tests determining the statistical difference across liver fibrosis risk groups. Analyses were performed at a 5% significance level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 373 patients, there was a slight female predominance (53%). Overall, 2.7% were at high risk of advanced liver fibrosis, while 56% had suspected hepatitis steatosis (MASLD), which aligns with global MASLD estimates in T2DM. Higher BMI was significantly associated with greater liver fibrosis risk (p=.002).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A small but clinically relevant proportion of patients with T2DM in the UAE are at high risk for advanced liver fibrosis. Incorporating non-invasive fibrosis risk assessment into routine diabetes care may facilitate early detection and specialist referral.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1719626","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:18:41Z","timestamp":1771305521000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of high-risk for advanced liver fibrosis using non-invasive scores among type 2 diabetes mellitus patients in the United Arab Emirates: a retrospective cross-sectional study"],"prefix":"10.3389","volume":"17","author":[{"given":"Najma","family":"Yaqoob","sequence":"first","affiliation":[{"name":"Graduate Medical Education, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaikha Salah","family":"Alhaj","sequence":"additional","affiliation":[{"name":"Graduate Medical Education, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayah Maher","family":"Al Obid","sequence":"additional","affiliation":[{"name":"Graduate Medical Education, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Alketbi","sequence":"additional","affiliation":[{"name":"Graduate Medical Education, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Alsuwaidi","sequence":"additional","affiliation":[{"name":"Graduate Medical Education, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia Ali","family":"Galadari","sequence":"additional","affiliation":[{"name":"Graduate Medical Education, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Graduate Medical Education, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heitham","family":"Ajlouni","sequence":"additional","affiliation":[{"name":"Consultant Endocrinologist, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima Kamal","family":"Abdelmannan","sequence":"additional","affiliation":[{"name":"Consultant Endocrinologist, Dubai Health","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"67","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: A meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/sjg.sjg_501_21","article-title":"Nonalcoholic fatty liver disease burden\u2014Saudi Arabia and United Arab Emirates, 2017\u20132020","volume":"28","author":"Alswat","year":"2022","journal-title":"Saudi J Gastroenterol"},{"key":"B5","unstructured":"IDF diabetes atlas\n          \n          \n          \n          2021"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-0407.2012.00222.x","article-title":"Prevalence and determinants of metabolic syndrome among healthy UAE adults","volume":"5","author":"Al Maskari","year":"2013","journal-title":"J Diabetes"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2018.314","article-title":"Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: A single-center experience","volume":"38","author":"Al Hamoudi","year":"2018","journal-title":"Ann Saudi Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/JCI122456","article-title":"Liver fibrosis in diabetes: Mechanisms and clinical implications","volume":"129","author":"Friedman","year":"2019","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0623","article-title":"Hepatic insulin resistance in nonalcoholic fatty liver disease: Impact on metabolic regulation","volume":"70","author":"Bril","year":"2021","journal-title":"Diabetes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101525","article-title":"Oxidative stress as a driver of liver fibrosis in nonalcoholic fatty liver disease","volume":"34","author":"Schuster","year":"2020","journal-title":"Redox Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1199-0","article-title":"The inflamed liver and atherosclerosis: A link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk","volume":"55","author":"Alkhouri","year":"2010","journal-title":"Digestive Dis Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12372","article-title":"Vitamin D and nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"38","author":"Eliades","year":"2013","journal-title":"Alimentary Pharmacol Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0217368","DOI":"10.1371\/journal.pone.0217368","article-title":"Prevalence of vitamin D deficiency and association with metabolic syndrome in a Qatari population","volume":"14","author":"Al-Dabhani","year":"2019","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13203","DOI":"10.1038\/s41598-021-92636-8","article-title":"Prevalence and determinants of nonalcoholic fatty liver disease (NAFLD) in a multi-ethnic Asian population","volume":"11","author":"Al-Rifai","year":"2021","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_238_20","article-title":"Nonalcoholic fatty liver disease in Saudi Arabia and the wider Middle East: Time for action","volume":"26","author":"Al-Hamoudi","year":"2020","journal-title":"Saudi J Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MCG.0000000000001532","article-title":"Nonalcoholic fatty liver disease in the Middle East: A growing medical problem","volume":"55","author":"Alkhouri","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100676","article-title":"Clinical characteristics and outcomes of NAFLD patients in Saudi Arabia: A multicenter study","volume":"27","author":"Alswat","year":"2022","journal-title":"Ann Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B23","unstructured":"Diabetes in the Middle East and North Africa: UAE country report\n          \n          \n          \n          2021"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25670","article-title":"The PNPLA3 rs738409 C>G variant influences the association between NAFLD and vascular disease","volume":"56","author":"Al-Serri","year":"2012","journal-title":"Hepatology"},{"key":"B25","unstructured":"National diabetes survey\n          \n          \n          \n          2020"},{"key":"B26","unstructured":"UAE national diabetes strategy 2021\u20132025\n          \n          \n          \n          2021"},{"key":"B27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000508833","article-title":"The prevalence of diabetes and pre-diabetes among the Dubai population: findings from Dubai household health surveys, 2014 and 2017","volume":"26","author":"Alawadi","year":"2020","journal-title":"Dubai Diabetes Endocrinol J"},{"key":"B28","volume-title":"NAFLD\/NASH: Rising prevalence and the treatment challenges in the Middle East","year":"2023"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.11.003","article-title":"Underdiagnosis of MASLD in the UAE: A retrospective analysis","volume":"78","author":"Al Dhaleei","year":"2023","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus\u2014mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol hepatology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-1567","article-title":"The glycemic paradox in MASLD: Mechanisms and clinical implications","volume":"46","author":"Bril","year":"2023","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden\u2013Saudi Arabia and United Arab Emirates, 2017\u20132030","volume":"24","author":"Alswat","year":"2018","journal-title":"Saudi J gastroenterology: Off J Saudi Gastroenterol Assoc"},{"key":"B34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.12816\/0048732","article-title":"Prevalence and trends of overweight and obesity amongst Saudi school children, a study done by using three noninvasive methods","volume":"10","author":"Shaikh","year":"2016","journal-title":"Int J Health Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32364","article-title":"Poor glycemic control predicts liver fibrosis in type 2 diabetes: The PIVENS trial","volume":"75","author":"Cusi","year":"2022","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e00123","DOI":"10.1002\/hep4.1856","article-title":"Mitochondrial dysfunction in lean MASLD: A prospective cohort study","volume":"7","author":"Feldstein","year":"2023","journal-title":"Hepatol Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9664-7","article-title":"The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool","volume":"10","author":"Al-Hamoudi","year":"2016","journal-title":"Hepatol Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis","volume":"34","author":"Paradis","year":"2001","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00608-8","article-title":"Hepatic fibrosis 2022: Mechanisms and therapeutic targets","volume":"19","author":"Friedman","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32364","article-title":"Obesity and MASLD: A systematic review and meta-analysis","volume":"76","author":"Loomba","year":"2022","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2022-108542","article-title":"PNPLA3 and TM6SF2 variants in Arab populations: Implications for MASLD","volume":"60","author":"Romeo","year":"2023","journal-title":"J Med Genet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","article-title":"Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus","volume":"14","author":"Targher","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.11.023","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in MASLD","volume":"164","author":"Siddiqui","year":"2023","journal-title":"Gastroenterology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00803-3","article-title":"Metabolic inflammation in MASLD: Mechanisms and therapeutic implications","volume":"23","author":"Tilg","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.025","article-title":"Severe obesity and liver fibrosis: A multicenter biopsy study","volume":"78","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"B47","unstructured":"IDF diabetes atlas\n          \n          \n          \n          2023"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2011.135","article-title":"Nutrition transition in the United Arab Emirates","volume":"65","author":"Ng","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1892","article-title":"Genetic variants in PNPLA3 and TM6SF2 in Arab populations with MASLD","volume":"6","author":"Alkhouri","year":"2022","journal-title":"Hepatol Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0284321","DOI":"10.1371\/journal.pone.0284321","article-title":"Physical inactivity and dietary patterns in UAE adults: A cross-sectional study","volume":"18","author":"Al Junaibi","year":"2023","journal-title":"PloS One"},{"key":"B51","volume-title":"National nutrition survey report","year":"2023"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2015.275","article-title":"Prevalence and correlates of overweight status among Saudi school children","volume":"35","author":"Al-Muhaimeed","year":"2015","journal-title":"Ann Saudi Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"B54","volume-title":"Global action plan on physical activity 2023-2030","year":"2023"},{"key":"B55","first-page":"78","article-title":"Healthcare access disparities among UAE nationals and expatriates","volume":"12","author":"Al Zaabi","year":"2021","journal-title":"UAE Med J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.12.031","article-title":"Fibrosis severity in lean vs. obese MASLD: A multicenter biopsy study","volume":"74","author":"Younes","year":"2021","journal-title":"J Hepatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00714-7","article-title":"Non-invasive tests for liver fibrosis in MASLD: Current evidence and future directions","volume":"20","author":"Tapper","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.04.004","article-title":"Mechanistic insights into insulin resistance and MASLD pathogenesis","volume":"35","author":"Samuel","year":"2022","journal-title":"Cell Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1719626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:18:43Z","timestamp":1771305523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1719626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":58,"alternative-id":["10.3389\/fendo.2026.1719626"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1719626","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"article-number":"1719626"}}